Literature DB >> 1284562

Differential analgesic effects of aspirin-like drugs.

K Brune1, S Menzel-Soglowek, H U Zeilhofer.   

Abstract

Tissue damage, including that due to surgical manipulation, results in 2 distinct but connected changes in the pain perception pathway. Firstly, cells disintegrate at the site of tissue damage and release mediators, including prostaglandins. These mediators transform fine nerve endings, particularly high-threshold mechanoceptors, into nociceptors. In other words, fine nerve endings that are not normally activated by mechanical pressure or temperature changes become very sensitive and are depolarised after minor mechanical or thermal changes. Secondly, in the central nervous system (CNS) and, particularly, in the dorsal horn of the spinal cord, reflex activity is increased, metabolic activity of the neuronal cells is enhanced and, chronically, major rearrangements of mediator production and electrical activity of the dorsal horn cells may be observed. Both types of change contribute to the well known phenomenon of hyperalgesia, which is regularly observed in connection with tissue damage, including that produced by surgical manipulation. It has been shown that aspirin-like drugs reduce the enhanced nociceptor activity in damaged tissue, probably as a result of prostaglandin synthesis inhibition. Recently, there have been indications that these drugs may have an additional mechanism of action in the spinal cord or higher parts of the CNS. Using the pure enantiomers of flurbiprofen in pharmacodynamic experiments in the rat, we have observed that the R- and S-enantiomers may exert differential analgesic effects. The R-enantiomer, which does not inhibit cyclo-oxygenase in vitro, was almost as effective as the S-enantiomer, which does inhibit prostaglandin synthesis in different models of pain and nociception.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1284562     DOI: 10.2165/00003495-199200445-00008

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  38 in total

1.  Antipyretic analgesics inhibit prostaglandin release from astrocytes and macrophages similarly.

Authors:  R Lanz; P Polster; K Brune
Journal:  Eur J Pharmacol       Date:  1986-10-14       Impact factor: 4.432

2.  Hypothalamic monoaminergic mechanisms of aspirin-induced analgesia in monkeys.

Authors:  K W Shyu; M T Lin
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

3.  Salicylates in rheumatoid arthritis: pharmacokinetics and analgesic response.

Authors:  G G Graham; G D Champion; R O Day; A L Kaski; L G Hills; P D Paull
Journal:  Agents Actions Suppl       Date:  1977

4.  Inhibition of prostaglandin synthetase by aspirin-like drugs in different microsomal preparations.

Authors:  A Dembinska-Kieĉ; A Zmuda; J Krupinska
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1976

Review 5.  Salicylates: molecular mechanism of therapeutic action.

Authors:  D C Atkinson; H O Collier
Journal:  Adv Pharmacol Chemother       Date:  1980

6.  Spontaneous and evoked release of prostaglandins from cerebral cortex of anesthetized cats.

Authors:  P W Ramwell; J E Shaw
Journal:  Am J Physiol       Date:  1966-07

7.  Central and peripheral antialgesic action of aspirin-like drugs.

Authors:  S H Ferreira; B B Lorenzetti; F M Corrêa
Journal:  Eur J Pharmacol       Date:  1978-12-15       Impact factor: 4.432

8.  Piroxicam-induced analgesia: evidence for a central component which is not opioid mediated.

Authors:  A Fabbri; G Cruccu; P Sperti; M Ridolfi; T Ciampani; M G Leardi; S Ferracuti; V Bonifacio
Journal:  Experientia       Date:  1992-12-01

9.  Effect of aspirin on serotonin and met-enkephalin in brain: correlation with the antinociceptive activity of the drug.

Authors:  A Groppetti; P C Braga; G Biella; M Parenti; L Rusconi; P Mantegazza
Journal:  Neuropharmacology       Date:  1988-05       Impact factor: 5.250

10.  Central effects of zomepirac on pain evoked by intraneural stimulation in man.

Authors:  W Schady; H E Torebjörk
Journal:  J Clin Pharmacol       Date:  1984-10       Impact factor: 3.126

View more
  5 in total

Review 1.  Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management.

Authors:  J C Gillis; R N Brogden
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

Review 2.  Preclinical and clinical development of dexketoprofen.

Authors:  D Mauleón; R Artigas; M L García; G Carganico
Journal:  Drugs       Date:  1996       Impact factor: 9.546

3.  Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors.

Authors:  N Voilley; J de Weille; J Mamet; M Lazdunski
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

4.  Involvement of brain serotonergic system in the antinociceptive action of acetylsalicylic acid in the rat.

Authors:  L A Pini; M Sandrini; G Vitale
Journal:  Inflamm Res       Date:  1995-01       Impact factor: 4.575

Review 5.  Pain treatment in multimorbid patients, the older population and other high-risk groups. The clinical challenge of reducing toxicity.

Authors:  C H Wilder-Smith
Journal:  Drug Saf       Date:  1998-06       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.